Almac Group

Activities: Manufacturing Ingredients Packaging Regulatory Research & Development Analysis

Trending Articles

  1. Navigating AI Integration in medical device manufacturing: risks, requirements and best practices This article explores the regulatory, technical and strategic considerations associated with integrating AI into medical devices, highlighting SaMD classification, compliance...
  2. Destination Russia for new NYK Logistics warehouse Logistics specialist NYK is expanding its market presence with the launch of new warehousing operation in Moscow, Russia.
  3. BASF announces up to 20% price increase on pharmaceutical excipients and selected APIs BASF Pharma Solutions has implemented an immediate global price adjustment of up to 20% across its pharmaceutical excipients and selected active pharmaceutical ingredients...
  4. Adragos Pharma acquires Sanofi's Maisons-Alfort sterile fill-finish facility to strengthen European injectables network Global CDMO Adragos Pharma has completed the acquisition of one of Europe's largest sterile injectables manufacturing sites from Sanofi in Maisons-Alfort, France, adding...
  5. Pfizer agrees sale of consumer healthcare business to J&J Pfizer Inc has reached an agreement to sell its consumer healthcare business to Johnson & Johnson (J&J) for US$16.6bn (euro13.2bn) in cash.

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Manufacturing Chemist Stand Side with Almac Group

We discover what exhibitors at CPHI 2025 are showcasing LIVE!
Finance

Almac announces multi-million-pound investment in Singapore

Almac Group has announced a multi-million-pound investment to expand its facility in Singapore, as the company marks ten years of operations in the country
Manufacturing

Almac invests $48 million to advance integrated eClinical technologies

New platform unifies trial operations, data, and systems to streamline complex clinical studies
Manufacturing

Strategic outsourcing in pharma: building resilient partnerships for a complex future

In an era marked by rapid scientific advancement, increasing regulatory complexity and global supply chain volatility, the pharmaceutical industry faces unprecedented challenges. The need for agility, innovation and resilience is reshaping the traditional paradigms of drug development and manufacturing
Manufacturing

Almac expands bioavailability capabilities to address a critical need in drug development

Almac Group has completed a multimillion-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK
Analysis

Almac Group expands US analytical capacity with new stability chambers in Souderton, PA

This $2 million investment builds on the multi-million-dollar expansion of global analytical services and reinforces Almac’s commitment to meeting growing client demand
Manufacturing

Almac completes a multi-million-pound investment enhancing cold chain capabilities in Craigavon

Almac Clinical Services, part of the Almac Group, has completed a multi-million-pound investment to enhance cold chain capabilities at its global headquarters in Craigavon, Northern Ireland
Subscribe now